Percutaneous mitral repair with the MitraClip

F. Maisano, O. Alfieri, G. La Canna

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Mitral regurgitation (MR) is associated with poor prognosis and high incidence of clinical events if left untreated. To reduce the invasiveness of the surgical approach, different types of trans-catheter procedures are becoming available. The MitraClip procedure (Abbott Vascular Inc. Menlo Park, CA) is yet the only available at the moment. The procedure is used to treat high risk surgical candidates with either functional or degenerative MR. Recent trials have shown that the procedure is safer than surgery, although less effective. Efficacy of the procedure depends on several factors, including patient selection, anatomy of the valve and the experience of the operators. However, when treating high risk patients a suboptimal repair obtained with low risk can be a acceptable outcome. In the future, novel devices, improved knowledge, more efficient imaging and transcatheter mitral prosthetic valve implantation may expand the indications to those patients currently not treated by MitraClip for anatomical unsuitability, as well as may improve the results both in term of early efficacy and long term durability.

Original languageEnglish
JournalAnnales Francaises d'Anesthesie et de Reanimation
Volume30
Issue numberSUPPL. 1
DOIs
Publication statusPublished - May 2011

Fingerprint

Mitral Valve Insufficiency
Mitral Valve
Patient Selection
Blood Vessels
Anatomy
Catheters
Equipment and Supplies
Incidence

Keywords

  • Mitraclip
  • Mitral repair
  • Percutaneous treatment
  • Transcatheter

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Percutaneous mitral repair with the MitraClip. / Maisano, F.; Alfieri, O.; La Canna, G.

In: Annales Francaises d'Anesthesie et de Reanimation, Vol. 30, No. SUPPL. 1, 05.2011.

Research output: Contribution to journalArticle

@article{a7c40704eca443f5b77c38aad176e7a7,
title = "Percutaneous mitral repair with the MitraClip",
abstract = "Mitral regurgitation (MR) is associated with poor prognosis and high incidence of clinical events if left untreated. To reduce the invasiveness of the surgical approach, different types of trans-catheter procedures are becoming available. The MitraClip procedure (Abbott Vascular Inc. Menlo Park, CA) is yet the only available at the moment. The procedure is used to treat high risk surgical candidates with either functional or degenerative MR. Recent trials have shown that the procedure is safer than surgery, although less effective. Efficacy of the procedure depends on several factors, including patient selection, anatomy of the valve and the experience of the operators. However, when treating high risk patients a suboptimal repair obtained with low risk can be a acceptable outcome. In the future, novel devices, improved knowledge, more efficient imaging and transcatheter mitral prosthetic valve implantation may expand the indications to those patients currently not treated by MitraClip for anatomical unsuitability, as well as may improve the results both in term of early efficacy and long term durability.",
keywords = "Mitraclip, Mitral repair, Percutaneous treatment, Transcatheter",
author = "F. Maisano and O. Alfieri and {La Canna}, G.",
year = "2011",
month = "5",
doi = "10.1016/S0750-7658(11)70008-9",
language = "English",
volume = "30",
journal = "Annales Francaises d'Anesthesie et de Reanimation",
issn = "0750-7658",
publisher = "Elsevier Masson",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Percutaneous mitral repair with the MitraClip

AU - Maisano, F.

AU - Alfieri, O.

AU - La Canna, G.

PY - 2011/5

Y1 - 2011/5

N2 - Mitral regurgitation (MR) is associated with poor prognosis and high incidence of clinical events if left untreated. To reduce the invasiveness of the surgical approach, different types of trans-catheter procedures are becoming available. The MitraClip procedure (Abbott Vascular Inc. Menlo Park, CA) is yet the only available at the moment. The procedure is used to treat high risk surgical candidates with either functional or degenerative MR. Recent trials have shown that the procedure is safer than surgery, although less effective. Efficacy of the procedure depends on several factors, including patient selection, anatomy of the valve and the experience of the operators. However, when treating high risk patients a suboptimal repair obtained with low risk can be a acceptable outcome. In the future, novel devices, improved knowledge, more efficient imaging and transcatheter mitral prosthetic valve implantation may expand the indications to those patients currently not treated by MitraClip for anatomical unsuitability, as well as may improve the results both in term of early efficacy and long term durability.

AB - Mitral regurgitation (MR) is associated with poor prognosis and high incidence of clinical events if left untreated. To reduce the invasiveness of the surgical approach, different types of trans-catheter procedures are becoming available. The MitraClip procedure (Abbott Vascular Inc. Menlo Park, CA) is yet the only available at the moment. The procedure is used to treat high risk surgical candidates with either functional or degenerative MR. Recent trials have shown that the procedure is safer than surgery, although less effective. Efficacy of the procedure depends on several factors, including patient selection, anatomy of the valve and the experience of the operators. However, when treating high risk patients a suboptimal repair obtained with low risk can be a acceptable outcome. In the future, novel devices, improved knowledge, more efficient imaging and transcatheter mitral prosthetic valve implantation may expand the indications to those patients currently not treated by MitraClip for anatomical unsuitability, as well as may improve the results both in term of early efficacy and long term durability.

KW - Mitraclip

KW - Mitral repair

KW - Percutaneous treatment

KW - Transcatheter

UR - http://www.scopus.com/inward/record.url?scp=79959497763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959497763&partnerID=8YFLogxK

U2 - 10.1016/S0750-7658(11)70008-9

DO - 10.1016/S0750-7658(11)70008-9

M3 - Article

C2 - 21703485

AN - SCOPUS:79959497763

VL - 30

JO - Annales Francaises d'Anesthesie et de Reanimation

JF - Annales Francaises d'Anesthesie et de Reanimation

SN - 0750-7658

IS - SUPPL. 1

ER -